Picard Medical, Inc. Stock: price and insider trades · United States
Picard Medical, Inc.: what insiders have been doing
Only a handful of insider records exist for Picard Medical, Inc., the last one from 3 June 2026, too few to describe a trend. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Insider Decl.
1
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2025FY ended December 2025 · cache
US$15.39
Analyst consensus
Income statement
RevenueUS$4.9M
Gross profit-US$204k-4% margin
EBITDA-US$21.1M-426% margin
Net income-US$27M-546.6% margin
Valuation
PER (forward)-3.4x
P/Book18.4x
Balance sheet & cash
Market capUS$36M
Total debtUS$7M
Free Cash Flow-US$15.7M
Debt / Equity92%
Profitability & ownership
ROA-93.6%
% insiders41.9%
% institutions6.4%
Last declaration on 3 June 2026
Declarations1 total
- 3,971,793 shares@ US$0.3172100.0% of flowCommonSEC144:0002095507-26-000002
1 of 1 declaration
About Picard Medical, Inc.
Picard Medical, Inc. is a company focused on developing innovative medical devices. It is listed on the XNAS market.
